{"title": "Bio&Bio preps for phase III with toxic shock vaccine, TSST-1", "author": "Nuala Moran", "url": "https://www.bioworld.com/articles/694170-bio-and-bio-preps-for-phase-iii-with-toxic-shock-vaccine-tsst-1", "hostname": "bioworld.com", "description": "Biomedical Research & Bio-Products (Bio&Bio) AG is laying plans for a phase III trial of its vaccine for preventing methicillin-resistant Staphylococcus aureus infections from sparking toxic shock syndrome, after delivering phase II data showing good safety and immunogenicity.", "sitename": "bioworld.com", "date": "2023-09-08", "cleaned_text": "Biomedical Research & Bio-Products (Bio&Bio) AG is laying plans for a phase III trial of its vaccine for preventing methicillin-resistant Staphylococcus aureus infections from sparking toxic shock syndrome, after delivering phase II data showing good safety "}